# Fate Therapeutics Inc: Form SC 13D/A, filed Mar 25, 2024

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: SC 13D/A
- Filed: 2024-03-25
- Accepted by EDGAR: Mar 25, 2024, 17:15 ET
- Period: not reported
- Accession: 0001104659-24-038492
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000110465924038492/tm249643d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000110465924038492/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000110465924038492/tm249643d1_sc13da.htm

Filed Mar 25, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-038492. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
